Naraka Bladepoint Season 13 features new hero Kylin Zhang

Naraka Bladepoint Season 13 features new hero Kylin Zhang

Season 13 of Naraka Bladepoint, Aeon Treasure, was launched, bringing new content and updates, including the new hero, Kylin Zhang. Check out more details about this iconic new character from the web novel series Time Raiders (Daomu Biji/DMBJ) below.

Kylin Zhang, the immortal last-generation patriarch of the Zhang clan, is truly over 110 years old despite his youthful appearance of 25.

In 2006, Kennedy Xu, a Chinese author, wrote Time Raiders, which quickly garnered a significant following due to its captivating story and extensive mythology.

The character Kylin Zhang, which was developed by Kennedy Xu, has been notably successful and is regarded as a critical figure in Time Raiders.

Kylin will be able to utilize his powerful skills to explore a variety of ancient tombs in quest of clues and memories. The Time Raiders character is perfectly aligned with his skill set, which is a seamless fusion of defensive and offensive combat that reflects the secret martial art mastery of his family. His combat abilities are nothing short of legendary.

Players can also look forward to additional new content. Naraka Bladepoint Season 13: Aeon Treasure features uncommon and exotic creatures from the ancient Chinese text, Classic of Mountains and Seas. The Creatures Myth cosmetics, which are inspired by this text, have been released in conjunction with the Fengshen Chronicles cosmetics, which incorporate elements of Chinese traditional culture.

The Kylin Zhang extreme outfit and the Fistblades extreme weapon skin will both be linked to traditional Chinese cultural themes in numerous ways. Not only do these both have a phonetic connection to Qilin, but they also represent the Qilin blood that flows within Kylin.

For those unaware, Naraka Bladepoint is a free-to-play melee battle royale for PC, consoles, and mobile platforms. To find out more, you can visit the game's website (https://ift.tt/trOCTPy).

Post a Comment

0 Comments